We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MEDICA 2021 + COMPAMED 2021 Re-Launches In-Person with Innovations Galore for Outpatient and Inpatient Care

By LabMedica International staff writers
Posted on 15 Nov 2021
Print article
Image: MEDICA 2021 (Photo courtesy of medica-tradefair.com)
Image: MEDICA 2021 (Photo courtesy of medica-tradefair.com)
The world's leading medical trade fair MEDICA and the international trade fair for suppliers to the medical technology industry, COMPAMED, returned to the Düsseldorf exhibition halls in Germany this year from 15 to 18 November 2021 in a presence format.

MEDICA’s 2,900 exhibitors and COMPAMED’s 490 exhibitors arrived from a total of 70 countries at the in-person events. Exhibitors brought their comprehensive portfolios of medical products, devices and instruments, including all the stages in their development, production and distribution processes, to present at MEDICA 2021 and COMPAMED 2021. The themed segments of MEDICA were based around meeting the entire range of needs for inpatient and outpatient care.

The MEDICA segments included: Lab technology & diagnostics, electrotherapy and medical technology, disposables and consumables, information and communication technology (digital health) and physiotherapy and orthopedic technology. The exhibitors at COMPAMED showcased the entire range of products and services that the supplier market provides for medical technology: from individual components and parts, along with innovative materials, to packaging solutions and high-tech processes such as additive manufacturing or complete contract manufacturing.

The significant industry trends and themes, such as an increased demand for digital healthcare solutions or the challenges that service providers face in conjunction with the new EU Medical Device Regulation (MDR), were reflected in the range of products and services that the exhibitors offered and also in the program of the forums and accompanying conferences that were integrated into the trade fairs. In line with the hybrid event concept, the lectures, discussions and award ceremonies for many of these program features could be followed either on-site at the forums’ stages in the trade fair halls or online via a live stream, accessible via the industry portals MEDICA.de and COMPAMED.de, depending upon the preferences of the ticket holder. Further highlights of MEDICA 2021’s program included the 44th German Hospital Conference (as a live stream) and the English language conferences DiMiMED and MEDICA MEDICINE + SPORTS CONFERENCE. These conferences gathered together experts in the fields of military and disaster medicine and in sports medicine and science at the venue in Düsseldorf.

The countries that generally asked for the largest areas before the pandemic were, once again, represented in full force at MEDICA. Italy, South Korea, Turkey, the US and other European nations, such as France, Spain, Great Britain and Poland, were all high on the list behind Germany. After Germany with around 550 exhibitors (MEDICA + COMPAMED), there was a particularly large number of companies from North America. More than 300 exhibitors presented their latest medical technology and medical product solutions to trade visitors from all sectors of the healthcare industry. In addition to the individual exhibitors, North American suppliers also participated in three US and one Canadian pavilion, which were supported by the respective government agencies. Canada's joint stand featured four of the 13 Canadian companies at MEDICA. Of the 223 US companies at MEDICA, 105 exhibited in the two US pavilions in Halls 3 (diagnostic equipment) and 16 (laboratory equipment), while 13 of the 63 US exhibitors at COMPAMED participated in the US pavilion in Hall 14.

"It is pleasant surprise to see such optimism throughout the industry. The broad consensus is that nothing can replace the valuable face-to-face exchanges that international trade shows like MEDICA and COMPAMED provide, said yan Klemm, Senior Business Development Manager at Messe Düsseldorf North America.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more